Clinical trial
A Clinical Study to Evaluate the Safety and Performance of DKL Crosslinked Sodium Hyaluronate 26 Dermal Filler for Cheek Augmentation.
NCT05021926 is registered in ClinicalTrials.gov with Dr. Korman Laboratories Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study to Evaluate the Safety and Performance of DKL Crosslinked Sodium Hyaluronate 26 Dermal Filler for Cheek Augmentation.
- Lead sponsor
- Dr. Korman Laboratories Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 30, 2021
- Completion date
- January 6, 2023
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aging problems